A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
To assess the changes in the trough Systolic Blood Pressure (SBP) and the percent changes in
Low Density Lipoprotein-Cholesterol (LDL-C) from baseline at Week 8 in the treatment period
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Atorvastatin Calcium